Pharmaceutical access and reimbursement professionals collaborating to solve patient access challenges.
PharmaARMs Insights

Access & Reimbursement Insights

Explore educational articles, federal policy updates, reimbursement workflow guidance, access strategy topics, case-based learning, and practical insights for pharmaceutical Access & Reimbursement professionals.

Content is intended for professional education only and should be verified against official sources, payer policies, plan documents, and appropriate internal guidance before being applied in practice.

New Drug Launches: Preventing Fires Before They Start
Liza P. Revelo, MBA Liza P. Revelo, MBA

New Drug Launches: Preventing Fires Before They Start

New drug launches require more than product readiness. Learn how proactive collaboration, discovery questions, and early access planning can help teams prevent barriers before they become urgent problems.

Read More
How AI Is Transforming Pharmaceutical Reimbursement Management – What Managers Need to Know Now
Liza P. Revelo, MBA Liza P. Revelo, MBA

How AI Is Transforming Pharmaceutical Reimbursement Management – What Managers Need to Know Now

Discover how AI is reshaping pharmaceutical reimbursement roles in the coming years. From faster prior authorizations and predictive analytics to smarter market access strategies, reimbursement managers can leverage tools like ReimbursementAI and IntegriChain ICyte to work more efficiently while focusing on high-impact strategic work. Learn what skills to build and how to prepare.

Read More
Why PharmaARMs Is Needed in Today’s Access & Reimbursement Marketplace
Liza P. Revelo, MBA Liza P. Revelo, MBA

Why PharmaARMs Is Needed in Today’s Access & Reimbursement Marketplace

Access and reimbursement professionals face a complex and ever-changing marketplace. PharmARMs was created to provide a trusted professional community where new and experienced ARMs can ask questions, share practical experience, explore source-based information, and learn from verified contributors when navigating difficult cases.

Read More